AMT vs PTHS · P/E 31, rev $10.64B vs rev $16.8M
American Tower Corp (AMT) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the AMT and PTHS stock pages for the full models.
Not investment advice.